Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

10

Revenue 2017

Lyrica

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lyrica was produced by Pfizer and Eisai.

Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’

Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’

This was driven by competition for epilepsy drug Lyrica (pregabalin) in the US, as well as lower revenue for key drugs in China due to the impact from the country’s

Vyndaqel a bright spot as Pfizer comes under pressure

Vyndaqel a bright spot as Pfizer comes under pressure The top line was however dragged down by the onset of generic competition in the US to severe pain drug Lyrica (pregabalin), which plunged to $433m from $1.32bn a year ... Upjohn sales were weak in the quarter, down 16% largely because of the impact of

Pfizer raises forecast following growth of biopharma business

Pfizer raises forecast following growth of biopharma business This was primarily due to volume declines of anti-seizure drug Lyrica (pregabalin), due to multi-source generic competition that began in July 2019 in the US.

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

Daiichi Sankyo starts mirogabalin trial in spinal injury pain rival to Pfizer’s big-selling Lyrica (pregabalin) brand which brought in $4.7bn last year despite generic competition in some markets. ... Like the original Lyrica formulation Daiichi Sankyo’s drug is dosed twice-daily.

The handover: Pfizer reshapes itself for a new era

The handover: Pfizer reshapes itself for a new era These new products will help offset the patent expiry of one of Pfizer’s biggest products, pain treatment Lyrica, which will see generics arrive at the end of December. ... autonomous. Created in the summer reshuffle, the Established Medicines division

1 2 3 4 5 6 7 8 9 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...